TY  - GEN
AU  - Garcia-Pavia, Pablo
AU  - Kristen, Arnt V
AU  - Drachman, Brian
AU  - Carlsson, Martin
AU  - Amass, Leslie
AU  - Angeli, Franca Stedile
AU  - Maurer, Mathew S
PY  - 2024
SN  - 1071-9164
UR  - https://hdl.handle.net/20.500.12105/25131
AB  - In the pivotal Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT), tafamidis significantly reduced mortality rates, leading to its approval in many countries for the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM)....
LA  - eng
PB  - CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
KW  - Transthyretin amyloid cardiomyopathy
KW  - real-world
KW  - survival
KW  - tafamidis
TI  - Survival in a Real-World Cohort of Patients With Transthyretin Amyloid Cardiomyopathy Treated With Tafamidis: An Analysis From the Transthyretin Amyloidosis Outcomes Survey (THAOS).
TY  - research article
ER  -